News and Comments

IDERA (IDRA): GOOD NEWS OFFSET SOMEWHAT BY SKEPTICISM NOT PESSIMISM

  Monday, March 04, 2013

Forgetting about Idera Pharmaceuticals (IDRA) seems to make its value sink, but failed to make it disappear. With a stock that sells at less than a three quarter of a dollar and a market of $20 million, lower than a new comer biotech having drugs still in preclinical lab testing, the firm was capable of drawing investors’ attention, riding new data about an attractive possibility of beating all existing approaches to treating psoriasis. The surprising data, which bring hopes in treating other autoimmune diseases, in addition to psoriasis were presented by James G. Krueger, M.D., PhD, of The Rockefeller University, at the Late-Breaking Research Symposium on March 2nd, 2013, during the American Academy of Dermatology Annual Meeting. More...


Recent Postings


Archive


Tags

Cytokinetics (CYTK) IDERA (IDRA) Jazz Pharmaceuticals (JAZZ) Biogen Idec (BIIB) GUARDIAN HEALTH Amgen (AMGN) Incyte (INCY) Array Pharmaceuticals (ARRY) Vertex (VRTX) ADVENTRIX (ANX) Pluristem (PSTI) ARCA (ABIO) Roche (RHHBY) Inovio (INO) Multiple Myeloma Benlysta (belimumab) Biocryst (BCRX) NANTKWEST (NK) Dendreon (DNDN) Trastuzumab-DM1 Regeneron (REGN) Theravance (THRX) Telaprevir KERYX (KERX) Illumina (ILMN) Roche (ROCHE) SYNTA (SNTA) Prosensa (RNA) OSI (OSIP) Seattle Genetics (SGEN) Galena (GALE) KITE (KITE) Abbott Laboratories (ABT) Gilead (GILD) ZALTRAP™ AERIE PHARMACEUTICALS Zerenex Agenus (AGEN) Elan (ELN) Velcade (bortezomib) Sangamo (SGMO) Idenix (IDIX) C4 Therapeutics Anadys (ANDS) ISIS (ISIS) Ziofpharm (ZIOP) Revlimid (lenolidamide) Exelixis (EXEL) BIOMARIN (BMRN) Aimmune Therapeutics (AIMT) Onyx (ONXX) VANDA (VNDA) Dynavax (DVAX) Prolor Biotech (PBTH) Intercept (ICPT) ImmunoGen (IMGN) ABBVIE (ABBV) SUNESIS PHARMACEUTICALS (SNSS) TOKAI (TKAOI) Sanofi-Aventis (SAN) Agenus (AGEN Sarepta (SRPT) Herceptin Human Genome Sciences (HGSI) Micromet (MITI) Xoma (XOMA) Sanofi (SNY) NEKTAR (NKTR)) HALOZYME (HALO) Bristol-Myers Squibb (BMY) Sanofi (SNA) Tysabri Auspex (ASPX) Ariad (ARIA) galapagos (GLPG) CompuGen (CGEN) Mirati Therapeutics (MRTX) Endometrial Cancer Intermune (ITMN) Anacor (ANAC) SERES THERAPEUTICS (MCRB) Genentech GlaxoSmithKline (GSK) Merck (MRK) Ridaforolimus Sequenom (SQNM) Valeant Pharmaceuticals International (VRX) Rapamune Alnylam (ALNY) Intrexon (XON) JUNO (JUNO)